Lymphoma is a general term for a group of cancers that originate in the lymphatic system and is the most common type of blood cancer. According to the Lymphoma Coalition, more than 62.000 people worldwide are diagnosed with Hodgkin lymphoma each year. In Belgium, Hodgkin is diagnosed in approximately 300 patients each year.
There are two major categories of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. Classical Hodgkin lymphoma is distinguished from other lymphoma types by the presence of one characteristic type of cell, known as the Reed-Sternberg cell. The Reed-Sternberg cell expresses CD30.
Takeda Oncology aspires to cure cancer by applying our commitment to science, to breakthrough innovation and to passion for improving patient care for people living with cancer around the world. Along with the global and local oncology communities, we make great strides in our fight against cancer. Our portfolio of paradigm-changing therapies combined with a dynamic, growing pipeline of investigational products have the potential to significantly improve patient outcomes across a number of types of cancer.